logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5829.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5829.produseast1
Showing 1 - 2 of 2 Items
Showing 1 - 2 of 2 Items
Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.
  • Current Page (2)
  • CSV
  • BibTeX
  • EndNote
  • All Results (2)
  • CSV
  • BibTeX
  • EndNote
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Immunogenicity of fractional doses of tetravalent A/C/Y/W135 meningococcal polysaccharide vaccine: Results from a randomized non-inferiority controlled trial in Uganda

Guerin PJ, Naess LM, Fogg C, Rosenqvist E, Pinoges LLP,  et al.
2008-12-02 • PLOS Neglected Tropical Diseases
2008-12-02 • PLOS Neglected Tropical Diseases
BACKGROUND: Neisseria meningitidis serogroup A is the main causative pathogen of meningitis epidemics in sub-Saharan Africa. In recent years, serogroup W135 has also been the cause of ep...
Journal Article
|
Research

Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine

Barnes GK, Naess LM, Rosenqvist E, Guerin PJ, Caugant DA
2011-06-08 • Scandinavian Journal of Immunology
2011-06-08 • Scandinavian Journal of Immunology
In the absence of an affordable conjugate meningococcal vaccine, mass vaccination campaigns with polysaccharide vaccines are the means to control meningitis epidemics in sub-Saharan Afri...